Medtronic PLC (MDT)
81.37
+0.77
(+0.96%)
USD |
NYSE |
May 31, 16:00
81.37
0.00 (0.00%)
Pre-Market: 20:00
Medtronic Enterprise Value: 123.93B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 123.93B |
May 30, 2024 | 122.92B |
May 29, 2024 | 124.09B |
May 28, 2024 | 124.75B |
May 24, 2024 | 125.13B |
May 23, 2024 | 123.94B |
May 22, 2024 | 129.69B |
May 21, 2024 | 128.91B |
May 20, 2024 | 128.05B |
May 17, 2024 | 129.90B |
May 16, 2024 | 129.53B |
May 15, 2024 | 128.32B |
May 14, 2024 | 127.77B |
May 13, 2024 | 126.75B |
May 10, 2024 | 125.86B |
May 09, 2024 | 125.75B |
May 08, 2024 | 124.16B |
May 07, 2024 | 124.62B |
May 06, 2024 | 124.44B |
May 03, 2024 | 124.35B |
May 02, 2024 | 123.34B |
May 01, 2024 | 123.30B |
April 30, 2024 | 122.45B |
April 29, 2024 | 123.04B |
April 26, 2024 | 121.58B |
Date | Value |
---|---|
April 25, 2024 | 122.24B |
April 24, 2024 | 123.74B |
April 23, 2024 | 124.95B |
April 22, 2024 | 123.99B |
April 19, 2024 | 122.54B |
April 18, 2024 | 122.16B |
April 17, 2024 | 122.01B |
April 16, 2024 | 122.24B |
April 15, 2024 | 123.54B |
April 12, 2024 | 123.41B |
April 11, 2024 | 126.12B |
April 10, 2024 | 126.33B |
April 09, 2024 | 128.28B |
April 08, 2024 | 127.10B |
April 05, 2024 | 129.29B |
April 04, 2024 | 128.44B |
April 03, 2024 | 129.87B |
April 02, 2024 | 130.14B |
April 01, 2024 | 132.56B |
March 28, 2024 | 132.73B |
March 27, 2024 | 132.42B |
March 26, 2024 | 128.15B |
March 25, 2024 | 127.54B |
March 22, 2024 | 127.32B |
March 21, 2024 | 127.76B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
109.59B
Minimum
Oct 27 2023
197.40B
Maximum
Sep 08 2021
149.04B
Average
148.12B
Median
Enterprise Value Benchmarks
Boston Scientific Corp | 119.63B |
Abbott Laboratories | 185.94B |
Axonics Inc | 3.090B |
Conmed Corp | 3.311B |
Inari Medical Inc | 2.806B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 654.00M |
Revenue (Quarterly) | 8.589B |
Total Expenses (Quarterly) | 7.38B |
EPS Diluted (Quarterly) | 0.49 |
Gross Profit Margin (Quarterly) | 64.56% |
Profit Margin (Quarterly) | 7.61% |
Earnings Yield | 3.38% |
Operating Earnings Yield | 5.10% |
Normalized Earnings Yield | 3.633 |